Inventor · disambiguated record
Rita De Santis
Also filed as: DE SANTIS RITA
11 granted patents·8 pending applications·58 citations·filing 1995–2018
87Inventor score
Files withSIGMA TAU IND FARMACEUTI9DE SANTIS RITA4ALFASIGMA SPA1ANASTASI ANNA MARIA1BOCCACCIO CARLA1
Top patents by PatentIndex Score
19 records- 0182US7683032B2Deglycosylated and desialidated long pentraxin PTX3SIGMA TAU IND FARMACEUTI·Filed 2005·Granted Mar 23, 2010·8 cites·25 claims
- 0275US8318911B2Anti-EpCAM antibody and uses thereofANASTASI ANNA MARIA·Filed 2008·Granted Nov 27, 2012·10 cites·30 claims
- 0373US8562947B2Oxidized avidin with high residency time in the treated tissuesDE SANTIS RITA·Filed 2008·Granted Oct 22, 2013·3 cites·6 claims
- 0470US5916773ARecombinant production of fusion proteins comprising erythropoietin and GM-CSF componentsMENARINI RICERCHE SPA·Filed 1995·Granted Jun 29, 1999·30 cites·21 claims
- 0568US7883889B2Antigen presenting cells, method for their preparation and their use for cancer vaccinesSIGMA TAU IND FARMACEUTI·Filed 2002·Granted Feb 8, 2011·1 cites·12 claims
- 0667US7425317B2Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapySIGMA TAU IND FARMACEUTI·Filed 2003·Granted Sep 16, 2008·4 cites·4 claims
- 0761US2005002920A1Antigen presenting cells, method for their preparation and their use for cancer vaccinesSIGMA TAU IND FARMACEUTI·Filed 2004·Application pending·0 cites
- 0858US7438908B2Anti-human tenascin monoclonal antibodySIGMA TAU IND FARMACEUTI·Filed 2003·Granted Oct 21, 2008·0 cites·25 claims
- 0958US6797722B2Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseasesSIGMA TAU IND FARMACEUTI·Filed 2002·Granted Sep 28, 2004·2 cites·6 claims
- 1053US2003119187A1Antigen presenting cells, method for their preparation and their use for cancer vaccinesFiled 2001·Application pending·0 cites
- 1147US7833981B2Deglycosylated and desialidated long pentraxin PTX3SIGMA TAU IND FARMACEUTI·Filed 2010·Granted Nov 16, 2010·0 cites·24 claims
- 1245US2004005643A1Anti-human tenascin monoclonal antibodySIGMA TAU IND FARMACEUTI·Filed 2003·Application pending·0 cites
- 1343US2005026980A1Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseasesSIGMA TAU IND FARMACEUTI·Filed 2004·Application pending·0 cites
- 1443US2021128740A1HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPYALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 1540US7989171B2Anti-human tenascin monoclonal antibodyTECNOGEN SCPA·Filed 2005·Granted Aug 2, 2011·0 cites·19 claims
- 1638US9872831B2Pharmaceutical composition of oxidised avidin suitable for inhalationDE SANTIS RITA·Filed 2012·Granted Jan 23, 2018·0 cites·6 claims
- 1738US2009110666A1Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumoursDE SANTIS RITA·Filed 2003·Application pending·0 cites
- 1833US2012237524A1Met inhibitors for enhancing radiotherapy efficacyBOCCACCIO CARLA·Filed 2012·Application pending·0 cites
- 1927US2013122033A1Fimh vaccine against urinary tract infections (uti)DE SANTIS RITA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rita De Santis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →